2002
DOI: 10.1097/00008571-200203000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione transferase GSTT1, broccoli, and prevalence of colorectal adenomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
141
2
1

Year Published

2002
2002
2009
2009

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(155 citation statements)
references
References 43 publications
11
141
2
1
Order By: Relevance
“…A similar protective effect of broccoli against colorectal adenomas has been reported for subjects who are null for GSTM1 [7]. If these relationships are confirmed it may mean that dietary advice needs to be targeted on individuals with a particular genetic profile.…”
supporting
confidence: 55%
“…A similar protective effect of broccoli against colorectal adenomas has been reported for subjects who are null for GSTM1 [7]. If these relationships are confirmed it may mean that dietary advice needs to be targeted on individuals with a particular genetic profile.…”
supporting
confidence: 55%
“…Also, epidemiologic observations suggest that consumption of certain cruciferous vegetables reduces the risk of colon cancer in individuals with GSTM1 null type. 40 Our results on GST and QR activities in liver and colon could explain the decrease in ACF formation and the colon cancer development in rats given silymarin during the initiation phase.…”
Section: Discussionmentioning
confidence: 69%
“…As with lung cancer, the relationship between cruciferous vegetable consumption and colorectal cancer risk may be complicated by genetic polymorphisms. The results of several recent epidemiological studies suggest that the protective effects of cruciferous vegetable consumption may be influenced by inherited differences in the capacity of individuals to metabolize and eliminate glucosinolate hydrolysis products [28][29][30][31] (see Genetic Polymorphisms, next).…”
Section: Colorectal Cancermentioning
confidence: 99%